Hengyu Lyu
7PUBLICATIONS
90CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance.Venu Thatikonda, Hengyu Lyu, Sabine Jurado
|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.Julien Dilly, Megan T Hoffman, Laleh Abbassi
|Feb 09, 2022
A functional genomic approach to actionable gene fusions for precision oncology.Jun Li, Hengyu Lu, Patrick Kwok-Shing Ng
|Oct 13, 2020
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.Chen Liu, Hengyu Lu, Hongyun Wang
|Aug 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.Huai-Xiang Hao, Hongyun Wang, Chen Liu
|May 10, 2019
SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors.Hengyu Lu, Chen Liu, Roberto Velazquez
Pageof 2
Frequent Collaborators
2 joint publications
Yiu Huen Tsang
2 joint publications
Timothy P Heffernan
1 joint publications
Ken Chen
1 joint publications
Haian Fu
1 joint publications
Eric Billy
1 joint publications
Matthew Shirley
1 joint publications
Huai-Xiang Hao
1 joint publications
Jun Li
1 joint publications
Patrick Kwok-Shing Ng
1 joint publications
Angeliki Pantazi
